CURTISS III ROY has a total of 15 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are VLP BIOTECH INC, CHILDREN S HOSPITAL OF EASTERN ONTARIO RES INST INC and COLD GENESYS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Fermentation | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Curtiss Iii Roy | 15 |
#2 | Kong Wei | 4 |
#3 | Wang Shifeng | 3 |
#4 | Wanda Soo-Young | 3 |
#5 | Roland Kenneth | 2 |
#6 | Liu Xinyao | 2 |
#7 | Zekarias Bereket | 2 |
#8 | Kong Qingke | 2 |
#9 | Mellata Melha | 1 |
#10 | Brenneman Karen | 1 |
Publication | Filing date | Title |
---|---|---|
US2013196394A1 | Compositions and methods for bacterial lysis and neutral lipid production | |
US2013209405A1 | Recombinant bacterium to decrease tumor growth | |
US2011256177A1 | Yersinia pestis vaccine | |
US2010303863A1 | Recombinant Edwardsiella bacterium | |
US2010285592A1 | Single expression vector for generation of a virus with a segmented genome | |
US2011256181A1 | Recombinant bacterium capable of eliciting a protective immune response against C. perfringens |